Direkt zum Inhalt
Merck

ERP-109S

Supelco

Pentaerythritol tetranitrate solution

10 mg/mL in acetonitrile, ampule of 5 mL, certified reference material, Cerilliant®

Synonym(e):

Pentaerythritol tetranitrate, PETN

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise


About This Item

Empirische Formel (Hill-System):
C5H8N4O12
CAS-Nummer:
Molekulargewicht:
316.14
MDL-Nummer:
UNSPSC-Code:
41116107
NACRES:
NA.24

Qualität

certified reference material

Qualitätsniveau

Leistungsmerkmale

Snap-N-Spike®/Snap-N-Shoot®

Verpackung

ampule of 5 mL

Hersteller/Markenname

Cerilliant®

Konzentration

10 mg/mL in acetonitrile

Anwendung(en)

environmental

Format

single component solution

Lagertemp.

−20°C

SMILES String

O=[N+]([O-])OCC(CO[N+]([O-])=O)(CO[N+]([O-])=O)CO[N+]([O-])=O

InChI

1S/C5H8N4O12/c10-6(11)18-1-5(2-19-7(12)13,3-20-8(14)15)4-21-9(16)17/h1-4H2

InChIKey

TZRXHJWUDPFEEY-UHFFFAOYSA-N

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Anwendung


  • Chromatographic Analysis of Pentaerythritol Tetranitrate: A study developed a liquid chromatographic-mass spectrometric method for analyzing pentaerythritol tetranitrate metabolites, validating its application in both ovine serum and human plasma samples. This research supports the use of pentaerythritol tetranitrate in cardiovascular studies, enhancing drug metabolism research and pharmacokinetic profiling (Städtler et al., 2024).

  • Biomedical Applications of Block Copolymers: Research explored the block sequence effects on the self-assembly behaviors of polypeptide-based penta-block copolymer hydrogels. While not directly about pentaerythritol tetranitrate, the study emphasizes the potential of similar nitrate compounds in developing pharmaceutical hydrogels and drug delivery systems, showcasing innovative materials in pharmacological research (Wang et al., 2024).

Rechtliche Hinweise

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

Ähnliches Produkt

Piktogramme

FlameExclamation mark

Signalwort

Danger

Gefahreneinstufungen

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2

Lagerklassenschlüssel

3 - Flammable liquids

WGK

WGK 2

Flammpunkt (°F)

35.6 °F - closed cup

Flammpunkt (°C)

2 °C - closed cup


Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

Leider sind derzeit keine COAs für dieses Produkt online verfügbar.

Wenn Sie Hilfe benötigen, wenden Sie sich bitte an Kundensupport

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

A Edtbauer et al.
The Journal of chemical physics, 132(13), 134305-134305 (2010-04-15)
Gas phase dissociative electron attachment (DEA) measurements to pentaerythritol tetranitrate (PETN) are performed in a crossed electron-molecular beam experiment at high-energy resolution and high sensitivity. DEA is operative at very low energies close to approximately 0 eV showing unique features
Xin Zhang et al.
Journal of colloid and interface science, 387(1), 175-179 (2012-09-15)
A simple technique for patterning organic materials using a surfactant assisted lift-off method is proposed. Thin films of various organic materials are prepared, and areas in contact with a surfactant coated poly(dimethylsiloxane) (PDMS) stamp are selectively removed. The general applicability
Andrey Pereverzev et al.
The Journal of chemical physics, 134(1), 014513-014513 (2011-01-12)
Normal vibrational modes for a three-dimensional defect-free crystal of the high explosive pentaerythritol tetranitrate were obtained in the framework of classical mechanics using a previously published unreactive potential-energy surface [J. Phys. Chem. B 112, 734 (2008)]. Using these results the
[Therapy with pentaerithrityltetranitrate (PETN). Established effectiveness, once again on trial].
MMW Fortschritte der Medizin, 153(7), 44-45 (2011-06-09)
[Options of NO substitution: proven and future methods. A pharmaceutical classic on the upswing].
MMW Fortschritte der Medizin, 153(24-25), 50-51 (2011-07-02)

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.